• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COVID-19: it's all about sepsis.

作者信息

Vincent Jean-Louis

机构信息

Department of Intensive Care, Erasme Hospital, Université libre de Bruxelles, 1070, Brussels, Belgium.

出版信息

Future Microbiol. 2021 Feb;16:131-133. doi: 10.2217/fmb-2020-0312. Epub 2021 Jan 25.

DOI:10.2217/fmb-2020-0312
PMID:33491491
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7837372/
Abstract
摘要

相似文献

1
COVID-19: it's all about sepsis.新型冠状病毒肺炎：一切都与脓毒症有关。
Future Microbiol. 2021 Feb;16:131-133. doi: 10.2217/fmb-2020-0312. Epub 2021 Jan 25.
2
Infliximab against severe COVID-19-induced cytokine storm syndrome with organ failure-a cautionary case series.英夫利昔单抗治疗重症新型冠状病毒肺炎所致细胞因子风暴综合征伴器官衰竭——警示性病例系列
Crit Care. 2020 Jul 17;24(1):444. doi: 10.1186/s13054-020-03158-0.
3
2019 Novel Coronavirus Pandemic: What Do We Know?2019新型冠状病毒大流行：我们了解什么？
S D Med. 2020 Jun;73(6):262-264.
4
Sepsis-associated severe interleukin-6 storm in critical coronavirus disease 2019.2019冠状病毒病危重症患者中与脓毒症相关的严重白细胞介素-6风暴
Cell Mol Immunol. 2020 Oct;17(10):1092-1094. doi: 10.1038/s41423-020-00522-6. Epub 2020 Sep 11.
5
Quantifying the Burden of Viral Sepsis During the Coronavirus Disease 2019 Pandemic and Beyond.量化2019年冠状病毒病大流行期间及之后病毒性脓毒症的负担
Crit Care Med. 2021 Dec 1;49(12):2140-2143. doi: 10.1097/CCM.0000000000005207.
6
IL-17A and TNF-α as potential biomarkers for acute respiratory distress syndrome and mortality in patients with obesity and COVID-19.白细胞介素-17A和肿瘤坏死因子-α作为肥胖合并新型冠状病毒肺炎患者急性呼吸窘迫综合征和死亡率的潜在生物标志物。
Med Hypotheses. 2020 Nov;144:109935. doi: 10.1016/j.mehy.2020.109935. Epub 2020 Aug 7.
7
Sepsis-associated acute kidney injury: is COVID-19 different?脓毒症相关急性肾损伤：新型冠状病毒肺炎是否有所不同？
Kidney Int. 2020 Dec;98(6):1370-1372. doi: 10.1016/j.kint.2020.08.009. Epub 2020 Sep 10.
8
COVID-19: a comparison to the 1918 influenza and how we can defeat it.新型冠状病毒肺炎：与1918年流感的比较以及我们如何战胜它。
Postgrad Med J. 2021 May;97(1147):273-274. doi: 10.1136/postgradmedj-2020-139070. Epub 2021 Feb 9.
9
Morphoproteomics Points to the IL-6 Cytokine Storm as One Factor and a Therapeutic Target in the Pathogenesis of Thrombosis in COVID-19 Patients.形态蛋白质组学指出，IL-6细胞因子风暴是新冠病毒肺炎患者血栓形成发病机制中的一个因素及治疗靶点。
Ann Clin Lab Sci. 2021 Jan;51(1):145-146.
10
Does Severe Acute Respiratory Syndrome Coronavirus 2 Cause Sepsis?严重急性呼吸综合征冠状病毒2会引发脓毒症吗？
Crit Care Med. 2020 Dec;48(12):1707-1709. doi: 10.1097/CCM.0000000000004601.

引用本文的文献

1
Longitudinal Metabolomics Reveals Metabolic Dysregulation Dynamics in Patients with Severe COVID-19.纵向代谢组学揭示了重症 COVID-19 患者的代谢失调动态。
Metabolites. 2024 Nov 25;14(12):656. doi: 10.3390/metabo14120656.
2
Compartmentalization of the inflammatory response during bacterial sepsis and severe COVID-19.细菌败血症和重症 COVID-19 期间炎症反应的区室化
J Intensive Med. 2024 Feb 27;4(3):326-340. doi: 10.1016/j.jointm.2024.01.001. eCollection 2024 Jul.
3
Disparities in Palliative Care Among Critically Ill Patients With and Without COVID-19 at the End of Life: A Population-Based Analysis.临终时患与未患新冠肺炎的重症患者在姑息治疗方面的差异：一项基于人群的分析。
J Clin Med Res. 2023 Dec;15(10-11):438-445. doi: 10.14740/jocmr5027. Epub 2023 Dec 9.
4
Anakinra authorized to treat severe coronavirus disease 2019; Sepsis breakthrough or time to reflect?阿那白滞素被批准用于治疗重症2019冠状病毒病；是脓毒症的突破还是反思的时候了？
Front Microbiol. 2023 Oct 19;14:1250483. doi: 10.3389/fmicb.2023.1250483. eCollection 2023.
5
Antibiotic failure: Beyond antimicrobial resistance.抗生素治疗失败：超越抗菌药物耐药性
Drug Resist Updat. 2023 Nov;71:101012. doi: 10.1016/j.drup.2023.101012. Epub 2023 Oct 18.
6
Persistence is key: unresolved immune dysfunction is lethal in both COVID-19 and non-COVID-19 sepsis.坚持是关键：未解决的免疫功能障碍在 COVID-19 和非 COVID-19 败血症中都是致命的。
Front Immunol. 2023 Sep 26;14:1254873. doi: 10.3389/fimmu.2023.1254873. eCollection 2023.
7
Use of Electronic Clinical Data to Track Incidence and Mortality for SARS-CoV-2-Associated Sepsis.利用电子临床数据追踪 SARS-CoV-2 相关脓毒症的发病率和死亡率。
JAMA Netw Open. 2023 Sep 5;6(9):e2335728. doi: 10.1001/jamanetworkopen.2023.35728.
8
The Impact of COVID-19 on Sepsis-Related Mortality in the United States.新冠疫情对美国脓毒症相关死亡率的影响
J Clin Med Res. 2023 Jun;15(6):328-331. doi: 10.14740/jocmr4937. Epub 2023 Jun 29.
9
During Sepsis and COVID-19, the Pro-Inflammatory and Anti-Inflammatory Responses Are Concomitant.在脓毒症和新冠肺炎期间，促炎反应和抗炎反应同时存在。
Clin Rev Allergy Immunol. 2023 Oct;65(2):183-187. doi: 10.1007/s12016-023-08965-1. Epub 2023 Jul 3.
10
Treatment Advances in Sepsis and Septic Shock: Modulating Pro- and Anti-Inflammatory Mechanisms.脓毒症和脓毒性休克的治疗进展：调节促炎和抗炎机制
J Clin Med. 2023 Apr 15;12(8):2892. doi: 10.3390/jcm12082892.